Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination

Heart

Volumn 82, Issue 2, 1999, Pages 176-182

  Biffi, M ^a   Boriani, G ^a   Bronzetti, G ^a   Capucci, A ^a   Branzi, A ^a   Magnani, B ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Atrial fibrillation; Electrophysiology; Flecainide; Isoprenaline; Propafenone

Indexed keywords

FLECAINIDE; PROPAFENONE;

ADULT; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HUMAN; MALE; PRIORITY JOURNAL; RR INTERVAL;

EID: 0032782319     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.82.2.176     Document Type: Article

References (25)

1. Allessie MA, Lammers WJEP, Bonke FIM, et al. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac electrophysiology and arrhythmias. Orlando: Grune and Stratton, 1985:265-75.
2. Rensma PL, Allessie MA, Lammers WJEP, et al. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1988;62:395-410.
3. Allessie M, Kirchhof C, Scheffer GJ, et al. Regional control of atrial fibrillation by rapid pacing in conscious dogs. Circulation 1991;84:1689-97.
4. Kirchhof C, Chorro F, Scheffer GJ, et al. Regional entrainment of atrial fibrillation studied by high-resolution mapping in open chest dogs. Circulation 1993;88:736-49.
5. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954 68.
6. Boriani G, Biffi M, Capucci A, et al. Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. Ann Intern Med 1997;126:621-5.
7. Donovan KD, Power BM, Hockings BEF, et al. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995;75:693-7.
8. Capucci A, Boriani G, Botto GL, et al. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 1994;74:503-5.
9. Capucci A, Biffi M, Boriani G, et al. Dynamic electrophysiologic behaviour of human atria during paroxysmal atrial fibrillation. Circulation 1995;92:1193-202.
10. Naccarelli GV, Rinkenberger RL, Dougherty AH, et al. Occurrence of atrial flutter with 1:1 AV nodal conduction during encainide and flecainide therapy [abstract]. Circulation 1989;80(suppl II):II-634.
11. Marcus FI. The hazards of using type IC antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation. Am J Cardiol 1990;66:366-7.
12. Nollo G, Del Greco M, Ravelli F, et al. ECG-oesophageal recording for beat-to-beat analysis of A-V conduction time variability. Computers in cardiology. New York: IEEE-Computer Society Press, 1992:433-6.
13. Wells JL, Kouchoukos NT, MacLean WAH, et al. Characterisation of atrial fibrillation in man: studies following open heart surgery. PACE 1978;1:426-38.
14. Lammers WJEP, Ravelli F, Disertori M, et al. Variations in human flutter cycle length induced by ventricular beats: evidence of a reentrant circuit with a partially excitable gap. J Cardiovasc Electrophysiol 1991;2:375-87.
15. Ravelli F, Disertori M, Cozzi F, et al. Ventricular beats induce variations in cycle length of rapid (type II) atrial flutter in man. Evidence of leading circle reentry. Circulation 1994;89:2107-16.
16. Suttorp MJ, Kingma HJ, Jessurin ER, et al. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-7.
17. Boriani G, Capucci A, Lenzi T, et al. Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. Chest 1995;108:355-8.
18. Capucci A, Lenzi T, Boriani G, et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without structural heart disease or with only systemic hypertension. Am J Cardiol 1992;70:69-72.
19. Wang J, Bourne GW, Wang Z, et al. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Circulation 1993;88:1030-44.
20. Wang Z, Pelletier LC, Talajic M, et al. Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit and dog tissues. Circulation 1990;82:274-83.
21. Capucci A, Boriani G, Rubino I, et al. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 1994;43:305-13.
22. Stambler BS, Wood M, Ellenbogen KA. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation. Circulation 1997;96:4298-306.
23. Murdock CJ, Kyles AE, Yeung-Lai Wah JE, et al. Atrial flutter in patients treated for atrial fibrillation with propafenone. Am J Cardiol 1990;66:755-7.
24. Feld GK, Chen PS, Nicod P, et al. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs. Am J Cardiol 1990;66:378-83.
25. Botto GL, Bonini W, Broffoni T, et al. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm. Pace 1994;17:2114-17.